T0	Outcomes 360 375	adverse effects
T1	Outcomes 387 399	neutropenia.
T2	Outcomes 570 578	efficacy
T3	Outcomes 759 787	higher neutrophil production
T4	Outcomes 865 908	PegFeG-CSF induced higher neutrophil counts
T5	Outcomes 913 946	showed greater sustained activity
T6	Outcomes 1022 1055	sustainable neutrophil production
T7	Outcomes 1136 1162	of neutralizing antibodies
T8	Outcomes 1201 1234	developed neutralizing antibodies
T9	Outcomes 1402 1429	HuG-CSF-induced neutropenia
T10	Outcomes 1442 1467	normal neutrophil numbers